445 Blockade of the inhibitory collagen receptor LAIR-1 with NC410, a LAIR2-Fc fusion protein, enhances anti-tumor activity of the bifunctional fusion protein bintrafusp alfa
Main Authors: | Jeffrey Schlom, Claudia Palena, Lucas Horn, Linjie Tian, Dallas Flies, Linda Liu, Solomon Langermann |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking human LAIR-collagen interaction
by: M Ines Pascoal Ramos, et al.
Published: (2021-06-01) -
Bullous pemphigoid secondary to bintrafusp alfa, a bifunctional fusion protein targeting TGF-beta and PD-L1
by: Claire J. Wiggins, BS, et al.
Published: (2021-07-01) -
Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies
by: Elizabeth Lamping, et al.
Published: (2020-07-01) -
Phase I study of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with pretreated biliary tract cancer
by: Do-Youn Oh, et al.
Published: (2020-06-01) -
Analysis of the tumor microenvironment and anti-tumor efficacy of subcutaneous vs systemic delivery of the bifunctional agent bintrafusp alfa
by: Yohei Ozawa, et al.
Published: (2021-01-01)